Chinese english Germany Japanese Korea

Afatinib impurity 45

Afatinib impurity 45 Struktur
99281-87-5
CAS-Nr.
99281-87-5
Englisch Name:
Afatinib impurity 45
Synonyma:
Afatinib Impurity 74;Afatinib impurity 45;Methyl (E)-4-aminobut-2-enoate;2-Butenoic acid, 4-amino-, methyl ester, (E)- (9CI)
CBNumber:
CB04869669
Summenformel:
C5H9NO2
Molgewicht:
115.13
MOL-Datei:
99281-87-5.mol
Request For Quotation

Afatinib impurity 45 Eigenschaften

Siedepunkt:
189.2±23.0 °C(Predicted)
Dichte
1.029±0.06 g/cm3(Predicted)
pka
8.39±0.29(Predicted)

Sicherheit

Afatinib impurity 45 Chemische Eigenschaften,Einsatz,Produktion Methoden

Afatinib impurity 45 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Afatinib impurity 45 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Standardpharm Co. Ltd. 		86-714-3992388
overseasales1@yongstandards.com United States 14332 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11922 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 		+8618627948422
 sale@hdimpurity.com China 3389 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 020-36607679 17825480238
 3008233717@qq.com China 9919 12
Jinan blalong chemical co. LTD 2710913286@.com
 1513643261@qq.com China 14246 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
 malulu@leyan.com China 54986 58
Guangzhou Juntang Technology Co., Ltd 020-36607679 13502246435
 sales@dmstandards.com China 10945 58
Molcoo Chemicals Inc. 18627756402
 3001051413@qq.com China 9544 58
Scinova Biotech(Guangzhou) Co., Ltd. 13268215580
 scinova_sales@163.com China 7023 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016; 18162595016
 3287908757@qq.com China 9122 58
  • Afatinib impurity 45
  • Afatinib Impurity 74
  • Methyl (E)-4-aminobut-2-enoate
  • 2-Butenoic acid, 4-amino-, methyl ester, (E)- (9CI)
  • 99281-87-5
Copyright 2019 © ChemicalBook. All rights reserved